Spanios
Houston, Texas, United States
Spanios Labs transforms precision oncology research by harnessing Patient-Derived Organoids (PDOs) and Tumoroids (PDTs) to accelerate drug development for rare cancers. Their COMPASS platform utilizes patient-specific 3D tumor models with intact tumor microenvironments (TME) to enable reproducible preclinical studies. By supporting any drug modality against solid cancer indications, Spanios helps scientists fast-track the search for novel cures. Serving drug developers and clinical oncologists, their efficacy-first model removes guesswork from therapeutic validation, aiming to bring hope to millions of patients through faster identification of effective treatments.
Company Info
- Founded
- 2017
- Website
- www.spanioslab.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Spanios?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.